BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Information letter on Optimark® products (gadolinium): New peel-off tracking label

Active substance: gadolinium

In order to enable a better understanding on the use of contrast agents containing gadolinium (Gd-based contrast agents) within the European Union, the European Commission has requested all manufacturers of contrast agents containing gadolinium to introduce peel-off tracking labels for these products.

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 73KB, File is accessible